TY  - JOUR

T1  - Prevalence of immature survival data for anti-cancer drugs presented to the National Institute for Health and Care Excellence between 2018-2022

JO  - Value in Health

UR  - https://eprints.whiterose.ac.uk/id/eprint/221638

PY  - 2024/12/24

AU  - Gibbons CL

AU  - Latimer NR

ED  - 

DO  - DOI: 10.1016/j.jval.2024.11.013

PB  - Elsevier BV

Y2  - 2025/10/31

ER  -